Navigation Links
Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span

MELBOURNE, Australia, March 23, 2007 /PRNewswire/ -- Scientists at WEHI have made a discovery with potentially profound implications for the care of patients, especially those undergoing cancer chemotherapy.

The research team led by Drs Benjamin Kile and David Huang has discovered that platelet life span is controlled by two key molecules. The discovery raises the prospect of developing a new drug to prolong the life span of platelets stored in blood banks, effectively increasing the availability of this life-saving blood product.

An undesirable side effect of cancer chemotherapy is extensive bruising and potentially life-threatening bleeding. This is caused by the unintended depletion of platelets, tiny circulating blood cells that are essential for blood clotting and wound healing. Consequently, the well being of some patients depends upon platelet transfusions, particularly during the vulnerable periods that follow anti-cancer treatment. The significant demand for high quality platelets, coupled with their short shelf life of only five days, presents major logistical challenges in clinical practice.

The scientific team has found that two specialised molecules act in opposition to each other to control platelet life span by regulating the process known as "apoptosis." This term refers to the normal and healthy self destruction of old, damaged and surplus cells. One protein (known as Bcl-xL) acts to preserve the life of the platelet, while the other protein (Bak) prepares the cell to self-destruct after its usual life span within the body - - about a week.

WEHI's Dr David Huang said, "Apoptosis is an essential process, common in other cells, but the central role it plays in controlling the life span of the highly specialised platelet has not been previously appreciated. With this new knowledge, we are in a much stronger position to devise better therapies for the management of plate
'"/>




Page: 1 2 3

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
5. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
6. Major Manufacturer of Unapproved and Adulterated Drugs
7. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
8. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
9. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
10. Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
11. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings

Post Your Comments:
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-Fi...a leading provider of advanced diagnostic and sp...nced today agreements with Roche Diagnostics Corpo...filiated consumables for the veterinary market. ...h/20000622/HESKALOGO ) ,, "Heska and Roche shar...
(Date:11/25/2009)... , PRINCETON, N.J., Nov. 25 /PRNewswire-Firs...nical stage pharmaceutical company committed to di...ugs to treat viral infections, reported financial ...09. At September 30, 2009 Pharmasset held $58.4 mi...estments. ,, Pipeline Update and 2009 Highlig...
(Date:11/25/2009)... , CHICAGO and STAFA, Switzerland, Nov. 25 /P...ading manufacturer of innovative hearing solutions... for Adults Conference, focusing on the special ne...t together leading experts in aging and audiology ... who work everyday with older people with hearing ...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Develop 12685 1Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Develop 12685 2Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Develop 12685 3ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps 28TM 29 4611 1Teens are heading in wrong direction 3A Likely to have sex but not use contraception 49313 1Teens are heading in wrong direction 3A Likely to have sex but not use contraception 49313 2
...y Initiated Following Success with 8 Patients, PR...n Board: DSCI), a provider of advanced wound care ...scular and thoracic surgeons from the,University o...ings to,successfully treat 8 patients with deep st...metimes arises after open-heart surgeries. The dre...
...13 USHIFU, LLC, the clinical trial,management pro...is pleased,to announce conditional written approva...DA to begin a pivotal trial for the treatment of,r... in men who have failed,external beam radiation th... NYU School of Medicine and,medical monitor for th...
Other Medicine Technology:Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 2Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 3FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2
(Date:11/27/2009)...BEDFORD, Mass., Nov. 27 ..., a supplier of precision technology products and ...ual meeting of the Company,s shareholders has been...nd location of the meeting will be announced in du...ceived a requisition notice from Stephen Bershad, ...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today iss...rus genomic data. It shows that the lethality of ....5) during the virus,s current outbreak in the spr...ek of 2.0 (s.d. 0.1). The H1N1 infectivity count, ... Boston (PRWEB) November 27, 2009 -- Biotech f...
(Date:11/27/2009)...N FRANCISCO, Nov. 27 The...hat Blair Lambert, CFO/COO, will present at the NA... at the May Fair Hotel in London, England, on Wedn...To listen to a live broadcast of The Gymboree Corp...og on to www.gymboree.com, click on "Our Company" ...
(Date:11/27/2009)... NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ -...ssional cycling team dedicated to ethical sporting...mpions, announced today that it will become Team G... Optical as a new sponsor of the team. Transitions...aptive eyewear, offering the most advanced photoch...
(Date:11/27/2009)... XenaCare Holdings has announced that ...Foundation, one of the largest nonprofit organizat...alth education. , Delray ...ldings, Inc. (OTCBB: XCHO), a company specializing...mer healthcare products, has announced today that ...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...ional Products, Inc.,(PPI) has been commissioned t...ltimore, Maryland with a Clinical Skills and Simul...is center is on the eighth floor of the,outpatient...skills before they perform a procedure on or inter...
... Company,(Amex: FHC ) today announced that its Ch...ncial Officer, Donna Felch, will present at the Gr...h and 28th, 2008, at the Westin,Fort Lauderdale Ho... session., About the Growth and Value Investor Co...
...ent Approved in Nine Years for Children Sufferi...isease, ABBOTT PARK, Ill., Feb. 22 Abbott (NYSE:...and Drug Administration (FDA),approval to market H...n patients four years of age and older. In the,U.S...
...centric Medical,Inc., the global leader in devices...ay announced that results from the use of its Merc... in seventeen separate presentations,at the Intern...val System in patients suffering from acute ischem...
...Campaign with Launch of Online Video, Contest wit...Commercial,Jonas Brothers Surprise 750 Students at... Announce New Breakfast BREAKS Retail Product, WO...tional campaign to raise awareness about the,impor...
...ealth-care system cited as factors , , FRI...significantly higher prevalence of stroke than the...tional risk factors and barriers to health care fa...men had almost twice the chances of having a strok...
Other Medicine News:Health News:Professional Products, Inc. Integrates Clinical Skills and Simulation Center at the Johns Hopkins Hospital 2Health News:The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale 2Health News:The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 2Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 3Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 4Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 5Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 6Health News:Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis 7Health News:2008 International Stroke Conference Highlights Impact of Merci Retrieval System 2Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 2Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 3Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 4Health News:Stroke More Prevalent in U.S. Than in Europe 2
7.75mm Open Trephine Handle
MVR 20Ga Stiletto Blade
Schockett Double Ended Depressor w/Clip
Hardten Collector Sponge
Medicine Products: